FIBROGEN INC (FGEN)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenue | 1,348 | 2,739 | 46,333 | |
| Selling, general and administrative | 7,057 | 8,106 | 17,554 | |
| Restructuring charge | 393 | 126 | 18,554 | |
| Research and development | 5,865 | 9,175 | 21,708 | |
| Cost of goods sold | 85 | 252 | 5,295 | |
| Total operating costs and expenses | 13,400 | 17,659 | 63,111 | |
| Loss from operations | -12,052 | -14,920 | -16,778 | |
| Interest income and other income (expenses), net | 286 | 413 | 3,802 | |
| Interest expense | 2,009 | 2,257 | 4,994 | |
| Total interest and other, net | -1,723 | -1,844 | -1,192 | |
| Loss from continuing operations before income taxes | -13,775 | -16,764 | -17,970 | |
| Benefit from income taxes | -92 | 2 | 12 | |
| Loss from continuing operations | -13,683 | -16,766 | - | |
| Income from discontinued operations, net of tax | 6,080 | 21,405 | - | |
| Investment income (loss) | - | - | 898 | |
| Net loss | -7,603 | 4,639 | -17,084 | |
| Earnings per share, basic | -1.88 | 0.05 | -0.17 | |
| Earnings per share, diluted | -1.88 | 0.05 | -0.17 | |
| Weighted average number of shares outstanding, basic | 4,042,000 | 100,954,000 | 100,515,000 | |
| Weighted average number of shares outstanding, diluted | 4,042,000 | 100,954,000 | 100,515,000 | |